Documentation should include specific pain descriptors, location, radiation patterns, and response to standard analgesics (Ballard et al., 2008)
Typical protocol: Dose: 0.51.5 mg subcutaneously 23x/week Often cycled: 4 weeks on, 2 weeks off Multi-Peptide Blends: KLOW and GLOW Pre-mixed peptide blends like KLOW combine BPC-157, TB-500, and GHK-Cu in a single vial
[DOI] [PMC free article] [PubMed] [Google Scholar] 267.Grgic T., Grgic D., Drmic D., Sever A.Z., Petrovic I., Sucic M., Kokot A., Klicek R., Sever M., Seiwerth S., et al
Liposomal delivery significantly reduces this risk
Additionally, the role of this region in spatial memory, memory processing and storage, and behavior is well known (Strange et al., 2014)
Third, dose-ranging animal safety studies focused specifically on copper accumulation across repeated systemic dosing would define whether a therapeutic window plausibly exists